Kaiwo Technology Influenza A and B Kits
Taiwan·Risk Class 1·HANGZHOU GENESIS BIODETECTION AND BIOCONTROL CO., LTD;; EQUAL ACCESS TO SCIENTIFIC EXCELLENCE·Registered Sep 08, 2009 – Sep 08, 2014Cancelled- Analysis ID
- 139f1f31453f9cc1a7e26b612be2294b
- Customs Code
- DHA04600078802
- Manufacturer
- HANGZHOU GENESIS BIODETECTION AND BIOCONTROL CO., LTD;; EQUAL ACCESS TO SCIENTIFIC EXCELLENCE
- Manufacturer Country
- United States;;China
- Authorized Representative
- Kaiwu Technology Co., Ltd. Tainan Branch
- Intended Use
- Limited to the first level identification range of the Measures for the Administration of Medical Devices "Influenza Virus Serum Reagent (C.3330)".
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3330 流感病毒血清試劑
- Import Information
- Contract manufacturing;; Input;; Chinese goods
- Registration Date
- Sep 08, 2009
- Expiry Date
- Sep 08, 2014
- Cancellation Date
- Jun 25, 2018
- Status
- Logged out
- Reason
- 許可證已逾有效期
Access comprehensive regulatory information for Kaiwo Technology Influenza A and B Kits in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 139f1f31453f9cc1a7e26b612be2294b and manufactured by HANGZHOU GENESIS BIODETECTION AND BIOCONTROL CO., LTD;; EQUAL ACCESS TO SCIENTIFIC EXCELLENCE. The authorized representative in Taiwan is Kaiwu Technology Co., Ltd. Tainan Branch.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.